(SSYS) Stratasys - Overview
Stock: 3D Printers, Materials, Software
| Risk 5d forecast | |
|---|---|
| Volatility | 56.1% |
| Relative Tail Risk | -18.7% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.07 |
| Alpha | -45.79 |
| Character TTM | |
|---|---|
| Beta | 1.751 |
| Beta Downside | 2.015 |
| Drawdowns 3y | |
|---|---|
| Max DD | 71.08% |
| CAGR/Max DD | -0.24 |
EPS (Earnings per Share)
Revenue
Risks
Description: SSYS Stratasys March 05, 2026
Stratasys Ltd. provides polymer-based 3D printing solutions. The company offers various 3D printing systems, including PolyJet, FDM, stereolithography, Origin P3, and selective absorption fusion printers.
These systems support applications like additive manufacturing, tooling, and rapid prototyping across sectors such as automotive, aerospace, consumer products, and healthcare. The 3D printing sector is experiencing growth due to increased demand for customized manufacturing and rapid product development.
Stratasys also supplies 3D printing consumable materials for FDM, PolyJet, and stereolithography technologies. These materials are used in jigs and fixtures, investment casting, and injection mold or composite tooling.
The companys software offerings include GrabCAD, an additive manufacturing platform, GrabCAD Print for job programming, and GrabCAD Print Pro. It also provides GrabCAD Print scheduling software for printer operations management and GrabCAD IoT Platform for optimizing manufacturing productivity.
Stratasys utilizes a reseller and independent sales agent network for global distribution. This business model is common for technology hardware companies to reach diverse markets efficiently.
To further understand SSYSs market position, consider exploring detailed financial and operational analyses available on platforms like ValueRay.
Headlines to watch out for
- Industrial adoption of additive manufacturing drives system sales
- Material sales provide recurring revenue stream
- Competition from lower-cost 3D printing solutions impacts market share
- Global economic conditions influence capital expenditure on printers
Piotroski VR‑10 (Strict, 0-10) 1.5
| Net Income: -104.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA 1.66 > 1.0 |
| NWC/Revenue: 76.02% < 20% (prev 60.40%; Δ 15.62% < -1%) |
| CFO/TA 0.02 > 3% & CFO 17.7m > Net Income -104.3m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 3.57 > 1.5 & < 3 |
| Outstanding Shares: last quarter (85.7m) vs 12m ago 19.98% < -2% |
| Gross Margin: 43.58% > 18% (prev 0.44%; Δ 4314 % > 0.5%) |
| Asset Turnover: 52.40% > 50% (prev 55.59%; Δ -3.19% > 0%) |
| Interest Coverage Ratio: -3.97 > 6 (EBITDA TTM -61.4m / Interest Expense TTM 20.4m) |
Altman Z'' -15.00
| A: 0.39 (Total Current Assets 582.0m - Total Current Liabilities 163.0m) / Total Assets 1.07b |
| B: -2.26 (Retained Earnings -2.42b / Total Assets 1.07b) |
| C: -0.08 (EBIT TTM -80.8m / Avg Total Assets 1.05b) |
| D: -10.50 (Book Value of Equity -2.42b / Total Liabilities 230.9m) |
| Altman-Z'' Score: -16.34 = D |
Beneish M -3.16
| DSRI: 1.09 (Receivables 160.5m/153.0m, Revenue 551.1m/572.5m) |
| GMI: 1.01 (GM 43.58% / 44.19%) |
| AQI: 0.87 (AQ_t 0.25 / AQ_t-1 0.29) |
| SGI: 0.96 (Revenue 551.1m / 572.5m) |
| TATA: -0.11 (NI -104.3m - CFO 17.7m) / TA 1.07b) |
| Beneish M-Score: -3.16 (Cap -4..+1) = AA |
What is the price of SSYS shares?
Over the past week, the price has changed by -12.18%, over one month by -26.25%, over three months by -10.76% and over the past year by -12.83%.
Is SSYS a buy, sell or hold?
- StrongBuy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the SSYS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 12.3 | 48.7% |
| Analysts Target Price | 12.3 | 48.7% |
SSYS Fundamental Data Overview March 07, 2026
P/S = 1.3847
P/B = 0.9811
P/EG = 2.0632
Revenue TTM = 551.1m USD
EBIT TTM = -80.8m USD
EBITDA TTM = -61.4m USD
Long Term Debt = 19.9m USD (estimated: total debt 26.5m - short term 6.60m)
Short Term Debt = 6.60m USD (from shortTermDebt, last quarter)
Debt = 26.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -68.0m USD (from netDebt column, last quarter)
Enterprise Value = 559.4m USD (777.5m + Debt 26.5m - CCE 244.5m)
Interest Coverage Ratio = -3.97 (Ebit TTM -80.8m / Interest Expense TTM 20.4m)
EV/FCF = -176.7x (Enterprise Value 559.4m / FCF TTM -3.17m)
FCF Yield = -0.57% (FCF TTM -3.17m / Enterprise Value 559.4m)
FCF Margin = -0.57% (FCF TTM -3.17m / Revenue TTM 551.1m)
Net Margin = -18.92% (Net Income TTM -104.3m / Revenue TTM 551.1m)
Gross Margin = 43.58% ((Revenue TTM 551.1m - Cost of Revenue TTM 310.9m) / Revenue TTM)
Gross Margin QoQ = 45.98% (prev 40.95%)
Tobins Q-Ratio = 0.52 (Enterprise Value 559.4m / Total Assets 1.07b)
Interest Expense / Debt = 20.47% (Interest Expense 5.42m / Debt 26.5m)
Taxrate = 21.0% (US default 21%)
NOPAT = -63.9m (EBIT -80.8m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 3.57 (Total Current Assets 582.0m / Total Current Liabilities 163.0m)
Debt / Equity = 0.03 (Debt 26.5m / totalStockholderEquity, last quarter 842.9m)
Debt / EBITDA = 1.11 (negative EBITDA) (Net Debt -68.0m / EBITDA -61.4m)
Debt / FCF = 21.49 (negative FCF - burning cash) (Net Debt -68.0m / FCF TTM -3.17m)
Total Stockholder Equity = 845.7m (last 4 quarters mean from totalStockholderEquity)
RoA = -9.92% (Net Income -104.3m / Total Assets 1.07b)
RoE = -12.33% (Net Income TTM -104.3m / Total Stockholder Equity 845.7m)
RoCE = -9.34% (EBIT -80.8m / Capital Employed (Equity 845.7m + L.T.Debt 19.9m))
RoIC = -7.54% (negative operating profit) (NOPAT -63.9m / Invested Capital 846.6m)
WACC = 12.50% (E(777.5m)/V(804.0m) * Re(12.37%) + D(26.5m)/V(804.0m) * Rd(20.47%) * (1-Tc(0.21)))
Discount Rate = 12.37% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 11.13%
[DCF] Fair Price = unknown (Cash Flow -3.17m)
EPS Correlation: -33.10 | EPS CAGR: 39.66% | SUE: 0.02 | # QB: 0
Revenue Correlation: -87.16 | Revenue CAGR: -4.04% | SUE: 0.20 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.03 | Chg7d=-0.010 | Chg30d=-0.010 | Revisions Net=-1 | Analysts=3
EPS current Year (2026-12-31): EPS=0.14 | Chg7d=-0.079 | Chg30d=-0.079 | Revisions Net=-1 | Growth EPS=-8.3% | Growth Revenue=+3.0%
EPS next Year (2027-12-31): EPS=0.16 | Chg7d=-0.180 | Chg30d=-0.180 | Revisions Net=+0 | Growth EPS=+16.4% | Growth Revenue=+3.7%
[Analyst] Revisions Ratio: -1.00 (0 Up / 1 Down within 30d for Next Quarter)